drugset / Trial / NCT00793429
Summary
In this study healthy volunteers received increasing doses of prucalopride to study the tolerability and cardiac safety of prucalopride. The study hypothesis was that prucalopride at doses up to 10 mg has no clinically relevant effect on the cardiovascular safety in healthy volunteers.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prucalopride | Small molecule | 6 mg | — |
| Subject | Prucalopride | Small molecule | 8 mg | — |
| Subject | Prucalopride | Small molecule | 10 mg | — |
Indications
No indication recorded.